Boothbay Fund Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.94M | Buy |
991,883
+203,531
| +26% | +$3.21M | 0.21% | 164 |
|
|
2025
Q4 | $14.4M | Buy |
788,352
+15,194
| +2% | +$256K | 0.37% | 80 |
|
|
2025
Q3 | $11.3M | Buy |
+773,158
| New | +$13.3M | 0.29% | 134 |
|
|
2024
Q3 | – | Sell |
-493,311
| Closed | -$5.52M | – | 1578 |
|
|
2024
Q2 | $5.52M | Sell |
493,311
-293,496
| -37% | -$2.46M | 0.17% | 202 |
|
|
2024
Q1 | $5.19M | Sell |
786,807
-302,899
| -28% | -$1.66M | 0.14% | 213 |
|
|
2023
Q4 | $4.93M | Buy |
1,089,706
+44,494
| +4% | +$165K | 0.17% | 201 |
|
|
2023
Q3 | $3.74M | Buy |
1,045,212
+31,375
| +3% | +$121K | 0.12% | 303 |
|
|
2023
Q2 | $3.74M | Sell |
1,013,837
-220,667
| -18% | -$818K | 0.11% | 328 |
|
|
2023
Q1 | $4.09M | Buy |
1,234,504
+183,119
| +17% | +$633K | 0.11% | 331 |
|
|
2022
Q4 | $4.08M | Sell |
1,051,385
-7,069,768
| -87% | -$21.8M | 0.12% | 296 |
|
|
2022
Q3 | $19.7M | Sell |
8,121,153
-2,239,247
| -22% | -$5.37M | 0.61% | 12 |
|
|
2022
Q2 | $20.5M | Sell |
10,360,400
-47,859
| -0.5% | -$94.2K | 0.64% | 7 |
|
|
2022
Q1 | $19M | Buy |
10,408,259
+2,124,399
| +26% | +$3.31M | 0.58% | 21 |
|
|
2021
Q4 | $11.7M | Buy |
8,283,860
+5,153,324
| +165% | +$6.77M | 0.37% | 59 |
|
|
2021
Q3 | $3.54M | Buy |
3,130,536
+2,903,067
| +1,276% | +$4.07M | 0.14% | 251 |
|
|
2021
Q2 | $364K | Buy |
227,469
+24,385
| +12% | +$42.9K | 0.01% | 1168 |
|
|
2021
Q1 | $357K | Buy |
203,084
+59,549
| +41% | +$136K | 0.02% | 1113 |
|
|
2020
Q4 | $280K | Buy |
143,535
+53,453
| +59% | +$112K | 0.01% | 976 |
|
|
2020
Q3 | $215K | Buy |
90,082
+1,582
| +2% | +$4.34K | 0.02% | 932 |
|
|
2020
Q2 | $259K | Sell |
88,500
-62,243
| -41% | -$179K | 0.02% | 737 |
|
|
2020
Q1 | $434K | Buy |
+150,743
| New | +$521K | 0.04% | 479 |
|
Other funds holding ADMA
VCM
VPM
N
